Brook Byers Overview

  • Investor Type
  • Angel
  • Investments
  • 7
  • Portfolio
  • 5

Brook Byers General Information

Description

Dr. Brook Byers is the Founder and serves as Advisor at Kleiner Perkins. He also serves as Advisor at Irisvision. Dr. Brook Byers serves as Board Member at Veracyte, Octave Bioscience, Crescendo Biologics, Enjoy Technology, Epiodyne, GRAIL, Irisvision, Newsela, Oculeve, Tethys. He is also an Angel Investor. He serves as Chairman at Verana Health. He served as a Board Member at Arsenal Biosciences. He also serves as Advisor at Mission Bay Capital He has been with the firm since 1977. A venture capital investor since 1972, Dr. Byers has been closely involved with more than 60 new technology-based ventures, many of which have become public companies. He formed the first life sciences practice group in the venture capital profession in 1984 and led KPCB to become a premier venture capital firm in the medical, healthcare, and biotechnology sectors. KPCB has invested in and helped build more than 110 life sciences companies that have developed hundreds of products to treat underserved medical needs for many millions of patients. He also serves as an Advisor at Mission Bay Capital. Dr. Byers was the founding president and then chairman of four biotechnology companies that were incubated in KPCB's offices and went on to become public companies with an aggregate market value of more than US$8 billion. He serves on the board of directors of CardioDX, CareDX, Elcelyx, Foundation Medicine, Oculeve, Cell Design Labs, Zephyr Health, and Newsela. He is a Co-Founder and serves as Board Member at NewSchools Venture Fund. He serves as Investment Advisor at Medical Technology Venture Partner. He previously served on the board of directors at Pacific Biosciences.

Contact Information

Primary Investor Type
Angel (individual)
Primary Office
  • 2750 Sand Hill Road
  • Menlo Park, CA 94025
  • United States
+1 (650) 000-0000

Brook Byers Investments (7)

Company Name Deal Date Deal Type Deal Size Industry Company Stage Lead Partner
Leyden Labs 18-Feb-2021 Early Stage VC 000.00 Drug Discovery Startup
000000 000000 05-Feb-2020 00000 00000 00000 Media and Information Services (B2B) Generating Revenue 00000 00000 00.0
000000000 (0000000 03-Feb-2020 00000 00000 0000 Enterprise Systems (Healthcare) Generating Revenue 00000 00000 00.0
0000000 0000000000 30-Jan-2020 00000 00000 0000 Biotechnology Generating Revenue 00000 00000 00.0
000000000 (0000000 29-Oct-2018 0000 00000 Diagnostic Equipment Generating Revenue 00000 00000 00.0
Verana Health 31-Jul-2018 Later Stage VC 0000 Media and Information Services (B2B) Generating Revenue 00000 00000 00.0
Verana Health 16-Jan-2015 Later Stage VC 00.00 Media and Information Services (B2B) Generating Revenue 00000 00000 00.0
To view Brook Byers’s complete investments history, request access »
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Brook Byers Investments by Industry, Year, and Region

Investments by Industry

Investments by Year

Investments by Region

PitchBook’s data visualizations quickly surface an investor’s historical investments—showing a breakdown of activity by industry, year and region.

Request a free trial

Brook Byers Team (1)

Name Title Deals Funds Boards Office
Brook Byers Ph.D Angel Investor 00 00 0 Menlo Park, CA
To view Brook Byers’s complete team members history, request access »

Brook Byers Co-Investors (30)

Name With Exits Lead Partner Series Industry
Casdin Capital 2 0 Series chart Industry bar
Define Ventures 0 0 Series chart Industry bar
GV 0 0 Series chart Industry bar
Khosla Ventures 0 0 Series chart Industry bar
Mayfield Fund 0 0 Series chart Industry bar
You’re viewing 5 of 30 co-investors. Get the full list »